Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03336333 · OUTCOME

Apparent Rate of Clearance of Zanubrutinib From Plasma (CL/F)CL/F

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL · Source last updated 2026-03-09

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Predose up to 12 hours postdose

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
anticipated Posting Date
2027-09
denom Units Selected
Participants
reporting Status
NOT_POSTED
time Frame
Predose up to 12 hours postdose
title
Apparent Rate of Clearance of Zanubrutinib From Plasma (CL/F)CL/F
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice